Structure Therapeutics (GPCR) PT Raised to $120 at Citizens
Tweet Send to a Friend
Citizens analyst Jonathan Wolleben raised the price target on Structure Therapeutics (NASDAQ: GPCR) to $120.00 (from $87.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
